A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to mCRPC
Related studies linked through entity extraction aliases.
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Disitamab Vedotin Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer：a Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study
- Status
- COMPLETED
- Phase
- N/A
The Radium-select Study
- Status
- RECRUITING
- Phase
- NA
Study of INKmune in Patients With mCRPC (CaRe Prostate)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
- Status
- RECRUITING
- Phase
- PHASE3
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)
- Status
- COMPLETED
- Phase
- PHASE2